Finance
Results: 4813-4824 of 48107

Ecosolex to Showcase Full-Scenario C&I and Residential Energy Storage at ees Europe 2026, Backed by Local European Delivery and Service

Laboratoires Pierre Fabre receives European Commission Approval for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC)






